All In Biotech

Drug Trial Radar · NCT03775434

A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis

An Open-label, Multicenter, Phase Ib Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects Aged 2 to 17 Years With Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Aug 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

28

Actual

Start

Dec 7, 2018

Primary completion

May 18, 2019

Study completion Jun 10, 2019

Sponsor

Lead sponsor
AOBiome LLCIndustry
Sponsor type
Industry
Collaborators
Novella Clinical
First posted
Dec 14, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An open-label, multicenter, Phase Ib study of B244 delivered as a topical spray to assess safety in pediatric subjects aged 2 to 17 years with atopic dermatitis Condition or disease Intervention/treatment Phase Atopic Dermatitis (Eczema) Biological: B244 Phase 1b

Conditions

  • Eczema
  • Atopic Dermatitis

Interventions

  • Experimental: B244Drug

    B244 suspension in 30ml/bottle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-emergent Adverse Events (TEAEs)as Assessed by CTCAE v4.0Time frame: Baseline to Day 28
  2. Number of Participants With Clinically Significant Changes From Baseline in Physical Exam.Time frame: Baseline to Day 28
  3. Mean Change in Blood Pressure From Baseline at Day 28Time frame: Baseline to Day 28
  4. Mean Change in Pulse Rate From Baseline at Day 28Time frame: Baseline to Day 28
  5. Mean Change in Body Temperature From Baseline at Day 28Time frame: Baseline to Day 28

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Dermatology Trial Associates

    Bryant, Arkansas

  • L.A. Universal Research Center, Inc.

    Los Angeles, California

  • The Indiana Clinical Trials Center

    Plainfield, Indiana

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • Skin Specialists, PC

    Omaha, Nebraska

  • Virginia Clinical Research, INC

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.